ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.
Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer,... Read More
Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want... Read More
It’s well known that women with certain hereditary genetic mutations, particularly BRCA1 and BRCA2, have an increased risk of breast... Read More
Men with prostate cancer can receive shorter courses of radiation therapy than what is currently considered standard, according to Justin... Read More
Cancer mortality rates vary considerably within the growing Hispanic population in the United States, with significant differences among the major... Read More
Researchers at Cold Spring Harbor Laboratory (CSHL) have discovered that a protein called Importin-11 protects the anti-cancer protein PTEN from... Read More
A team led by researchers of the Institute of Biomedicine of the University of Barcelona (IBUB) and the Research Institute... Read More
A report in The Journal of Molecular Diagnostics describes a biomarker, PITX2 DNA methylation, which is capable of distinguishing cancerous... Read More
When it comes to prostate cancer biopsies, risk and reality don’t always match up, according to research published online today... Read More
A team of scientists has identified MNX1 as a new oncogene – a gene than can cause cancer – that... Read More
